SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?


To: R>G> who wrote (1780)9/28/1998 7:56:00 PM
From: Guy.  Respond to of 4650
 
R>G> regarding your first two questions,i will refer
them to Ari and he could answer it more thoroughly.
(and i will pass it to the thread)
As to china,it is true that it is one of the hardest markets
to penetrate,but the negotiations are still on,and hopefully
Biomoda will penetrate this market at the near future.
This is an estimated $300m market so let's cross our fingers.
Ari told me that in China the minister of health can authorize
only one kind of the same product.So if Biomoda's kit is
authorized, then there will be no competition,the market
will be all Biomoda's.
Guy



To: R>G> who wrote (1780)9/28/1998 7:59:00 PM
From: R>G>  Read Replies (2) | Respond to of 4650
 
Ann Arbor News 9/20/98, slightly off topic, but in the ballpark
FLAT-PANEL SCREENS OFF RADAR
Area maker goes bust
By Rick Laglund
DETROIT Five years ago, the Clinton and Engler(governor of Michigan) administrations placed a $68 million bet that a small Michigan company could begin wresting the flat-panes video display industry away form the Asians.
Today the bet has gone bust. OIS Optical Imaging Systems Inc., one of just two domestic producers of advanced flat-panel video displays, is ceasing operations.
skip
In addition, a state-funded University of Michigan research center designed to help OIS become a major producer of these high-tech screens, may be merged with another U-M micro-electronics research center because of OIS's failure.
skip
"I think the OIS situation is not a positive in our efforts to bring flat-panes-display companies to Michigan," said Jim Tobin, a spokesman for the Michigan Jobs Commission.
Guardian has invested $135 million in OIS, but decided this week to end financial support because of OIS's continuing losses.
Skip
The company's assets will be liquidated.
skip
Flat-pane displays are used in everything from laptop computers to the instrument panels of fighter jets. Analysts expect the world market for these thin screens to grow to about $25 billion by 2004, up from about $5 billion in the early 1990s.
skip In 1993, the Clinton administration tried to kick start the U.S. flat-panel industry by giving OIS $48 million to build the nation's first major flat-panel manufacturing plant. The company also got various U.S. military contracts.
OIS built "active matrix liquid crystal display" panels, the kind that are popular in laptop computers and in sophisticated aircraft instrumentation.
Skip
And the U-M center's research may benefit automakers, who are exploring the use of flat-panel displays in instrument panels.

ADOT need any equipment?, might be able to pick some up cheap?
Maybe the Clinton and Engler administrations have millions more to give away?

Go Wolverines



To: R>G> who wrote (1780)9/28/1998 8:19:00 PM
From: Brad  Respond to of 4650
 
R>G>, Perhaps the Columbia/HCA article at this link will be of interest to you regarding Pap smears and Dr Geno Saccomanno's work (Dr Saccomanno is a key figure on Biomoda's Advisory Board)...

columbia.net



To: R>G> who wrote (1780)9/29/1998 9:24:00 PM
From: R>G>  Respond to of 4650
 
Thanks Brad, John White, Guy, Andrew T, Nutbuster and others.
You make it so easy for someone to learn about this company.
Best thread that I know of.

R>G>



To: R>G> who wrote (1780)10/1/1998 12:14:00 PM
From: Guy.  Read Replies (3) | Respond to of 4650
 
R>G>,as i promised you,i asked Ari those 2 questions
you asked me.Here what he answered me:
1.The technology can locate other tumor types.They've already
located 5 different tumor types.
2.Biomoda's technology can replace the PAP SMEAR with 100%
accuracy,but first they need to perform the clinical test on this just as with the lung cancer.
Guy